Monday, September 11 - Wednesday, September 13, 2017

An intensive, three day meeting utilizing the unique data from the Framingham Heart Study (FHS).

The mission of this three-day workshop is to enable young clinical investigators and clinician scientists (MDs and PhDs) with the tools and resources to use epidemiological data to perform cardiovascular translational research, using data from FHS as an example.

The meeting will be a combination of discussion sessions and hands on training.  Lecture sessions will focus on key topic areas led by leaders in the field where they will discuss how they have accessed FHS data to answer career-building questions. The hands-on experience on the computer will include instruction on how to access FHS data, how to analyze the data, and how to evaluate the utility of the data for collaborations and grant applications. In addition, individual career counseling sessions will be offered by senior investigators.




Emelia J. Benjamin, MD, ScM
Assistant Provost for Faculty Development, Boston University Medical Campus
Vice Chair, Faculty Development and Diversity (FDD), Dept. of Medicine
Professor of Medicine and Epidemiology
Boston University Schools of Medicine and Public Health

Patrick T. Ellinor, MD, PhD
Director, Cardiac Arrhythmia Service, Massachusetts General Hospital
Associate Professor, Harvard Medicine School
Associate Member, Broad Institute of Harvard and MIT

Caroline S. Fox, MD, MPH
Vice President, Merck Research Labs (MRL)
Head, Genetics and Pharmacogenomics (GpGx)

Jane E. Freedman, MD, FAHA
Professor of Medicine
Director, Translational Research
UMass Memorial Heart & Vascular Center
University of Massachusetts Medical School

Robert E. Gerszten, MD
Professor, Harvard Medical School
Chief, Division of Cardiovascular Medicine
Beth Israel Deaconess Medical Center

Andrew D. Johnson, PhD, FAHA
Tenure Track Investigator
Head, Biomedical Informatics, NHLBI Population Sciences Branch
The Framingham Heart Study

Martin G. Larson, SD
Research Professor of Biostatistics
Boston University School of Public Health
Co-Principal Investigator, The Framingham Heart Study

Daniel Levy, MD
Director, Framingham Heart Study
Branch Chief, Population Sciences Branch,
National Heart Lung and Blood Institute
Professor of Medicine, Boston University School of Medicine

James B. Meigs, MD, MPH, FAHA
Professor of Medicine, Harvard Medical School
Physician, Division of General Internal Medicine
Massachusetts General Hospital
Co-Director, MGH Clinical Research Program Clinical Effectiveness Research and Survey Unit
Associate Member, Broad Institute

Kiran Musunuru, MD, PhD, MPH, FAHA
Associate Professor of Cardiovascular Medicine and Genetics
Perelman School of Medicine at the University of Pennsylvania

Christopher J. O’Donnell, MD, MPH
Chief of Cardiology
Boston VA HealthCare
Associate Clinical Professor
Harvard Medical School
Director, Center for Population Genomics
Chief Scientist for the Million Veteran’s Program

Allan J. Walkey, MD, MSc
Assistant Professor of Medicine
Boston University School of Medicine


Target Audience

This course is intended for clinical investigators and clinician scientists from academic medical centers whose research focuses on cardiology, neurology, nephrology, orthopedics, vascular medicine and public health.


Program Directors

Vasan S. Ramachandran, MD
Program Chair
Jay and Louise Coffman Professor in Vascular Medicine
Professor of Medicine and Epidemiology
Chief, Section of Preventive Medicine & Epidemiology, Department of Medicine
Boston University Schools of Medicine & Public Health
Principal Investigator, The Framingham Heart Study

Presented by

The Framingham Heart Study (FHS) and the Boston University School of Medicine Center for Translational Epidemiology and Comparative Effectiveness Research and the Section of Preventive Medicine and Epidemiology.


Tuition and Cancelation Policy

Registration Only*:  $550
Registration with Accommodations (3 nights)*:   $775

*Registration fees include lunch and breaks each day, the opening dinner and course materials.


Substitutions may be made at any time without an additional charge. Refunds will be issued for all cancellations received two weeks prior to the start of the conference. Should cancellation occur within the two-week window, a credit will be issued, not a refund. A $50.00 administrative fee will be charged for all refunds and credits. “No shows” are subject to the full course fee. Cancellation/substitution(s) must be made in writing. Refunds or credits will not be issued once the conference has started. This course is subject to change or cancellation.



At the end of this course, participants will be able to use, analyze, and evaluate Framingham Heart Study data for grant applications.